字号·· | 护眼
卫报

澳大利亚放宽药店限制后,堕胎药的可及性激增近50%Abortion pill access jumps almost 50% after Australia eases restrictions for pharmacies

点「原文对照」整页切到原文,或双击某段只看那段的原文。

一名女子正准备服用两片米非司酮中的第一片,用于药物流产。澳大利亚药品管理局(TGA)已取消对这类药片处方的限制。摄影:查理·里德尔/美联社A woman prepares to take the first of two mifepristone pills for a medical abortion. Australia’s TGA has scrapped restrictions on the prescription of the pills. Photograph: Charlie Riedel/AP

在2023年规则放宽后,备有MS-2 Step药物的药店数量从2,228家增加到4,107家。研究人员表示,当处方限制放宽时,备有堕胎药的澳大利亚药店数量增加了近50%,这些发现表明堕胎非监管化促进了更安全、更快速的医疗保健。

The number of pharmacies stocking the MS-2 Step medication increased from 2,228 to 4,107 after rules relaxed in 2023 The number of Australian pharmacies stocking an abortion pill increased by almost 50% when prescribing restrictions were relaxed, with researchers saying the findings suggest deregulation of abortion promotes safer and faster healthcare.

周四在医学杂志《美国医学会杂志·网络开放版》(JAMA Network Open)上发表的一项研究审查了治疗用品管理局(Therapeutic Goods Administration)在2023年修改政策的影响,该修改意味着MS-2 Step药物可以由任何全科医生(GP)开处方。

A study published in the medical journal JAMA Network Open on Thursday examined the impact of changes by the Therapeutic Goods Administration in 2023 which meant the medication, MS-2 Step, could be prescribed by any GP.